MGMustafa Asım Gedikli

Mustafa Asım Gedikli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mustafa Asım Gedikli has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effects of diabetes complications on body composition, dietary intake, and metabolic parameters

    by Tuba Tekin, Başak İkra Yıldız, Şaziye Yoldaş, Mustafa Asım Gedikli

    Aim Diabetes is a metabolic disease characterized by hyperglycemia resulting from deficiencies in the effect or secretion of insulin. Diabetes leads to various acute and chronic complications. This study investigated the impact of complications on body composition, dietary habits, and biochemical parameters in individuals with type 2 diabetes. Methods The study included 42 diabetes patients with complications and 45 diabetic individuals without complications. A 24-hour dietary recall was conducted to assess nutritional status. The results of routine blood tests were analyzed to measure metabolic control. Measurements of participants’ body weight, height, body composition, and waist and hip circumferences were recorded. Body composition was assessed utilizing a portable bioelectrical impedance analyzer. Body composition was examined using body fat percentage, body water percentage, visceral fat percentage, muscle mass, and basal metabolic rate. Results Individuals with complications of diabetes had elevated body mass index (BMI), body fat percentage, visceral fat percentage, and waist and hip circumference (p > 0.05). They exhibited increased consumption of carbohydrates, dietary cholesterol, and saturated fats (p > 0.05). Additionally, HbA1c concentrations were higher and albumin concentrations were lower in individuals with diabetic complications (p < 0.05). Conclusıon The study findings indicate that complications in individuals with type 2 diabetes negatively impact metabolic parameters, body composition, and nutritional consumption. To mitigate the risk of complications in individuals with type 2 diabetes, dietary treatments should be implemented to enhance metabolic parameters and body composition.

  • The Effect of the Covid-19 Pandemic Process on Hba1c In Type 2 Diabetes Patients Applying to the Internal Medicine Outpatient Clinic

    by Fatih Orhan, Mustafa Asım Gedikli, Zekeriya Keskin

    The incidence and prevalence of Type 2 Diabetes Mellitus (DM) are increasing worldwide. Due to the restrictions, increased stress, and increased sedentary life during the pandemic, deterioration in diabetes control is expected. The aim of this study is to determine the effect of COVID-19 on HbA1c values and how it affects diabetes control. In our study, a total of 6217 diabetic patients were examined retrospectively in 5 separate periods (March 2018-February 2019, March 2019-February 2020, March 2020-February 2021, March 2021-February 2022, March 2022-February 2023). According to the HbA1c value; those with HbA1c values were classified as well-controlled, those between 7-9% as poorly controlled, and those >9% as very poorly controlled. In addition, LDL, HDL, cholesterol and fasting blood sugar values were recorded. There are significant differences between the groups in terms of HbA1c measurements (p<0.001). The lowest HbA1c value was found to be 7.61% in the measurement between March 2018 and February 2019, and the highest value was found to be 8.39% in the measurement between March 2020 and February 2021. The HbA1c very poor control rate was the highest in March 2020 and February 2021 (30.9%), and the good control rate was the highest in March 2018 and February 2019 (51.3%). In our study, HbA1c values and poorly controlled patient rates were found to be higher during the pandemic period. Considering this result, it can be said that the pandemic process caused deterioration in disease control in Type 2 diabetes patients.

  • Open Access

    Polymyxin B-Associated Acute Kidney Injury: Risk Factors and Short-Term Outcomes in a Single-Center Retrospective Cohort

    by Zekeriya Keskin, Mustafa Asim Gedikli

    Introduction. Polymyxin B (PMB) and other antibiotics in the polymyxin group are known to be nephrotoxic. In recent years, due to the increasing prevalence of antibiotic resistance, they have become a frequent treatment option for infections caused by multidrug-resistant Gram-negative bacteria. Our study aims to comprehensively examine the nephrotoxic effects and clinical characteristics of PMB in patients receiving treatment without dose reduction. Methods. This study included 176 patients, who were divided into two groups based on the presence or absence of acute kidney injury (AKI). The groups were analyzed for nephrotoxicity, associated risk factors, mortality, and other clinical characteristics. Results. Gender, pathogen, site of infection, comorbidities, additional nephrotoxic agents, duration of antibiotic use, and mechanical ventilation status were not identified as risk factors for AKI development. However, advanced age was found to be associated with nephrotoxicity (OR = 1.024, 95% CI 1.001–1.047; p = 0.037). Additionally, the mortality rate was higher in the AKI group (p = 0.001), although no significant difference was observed in the survival analysis (p = 0.189). Conclusions. PMB is commonly used in critically ill patients, and PMB-associated AKI tends to develop early during treatment. While most clinical characteristics were not independently associated with AKI, advanced age was identified as a significant risk factor. Therefore, close monitoring of renal function is recommended throughout PMB therapy.

  • Association Between Hepatorenal Index and Arterial Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    by Zekeriya Keskin, Maksut Alper Çelik, Ramazan Hilmi Sağlam, Nada Haroun, İrFan Atik, Mustafa Asım Gedikli


  • Open Access

    Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells

    by Ziad Joha, Oğuzhan Kalkan, Fatih Yulak, Mustafa Ergül, Mustafa Asım Gedikli

    Proton pump inhibitors (PPIs), including esomeprazole, impact the acidic tumor microenvironment, potentially influencing cancer cell behavior. By examining the combined effects of esomeprazole and cisplatin on SNU‐1 gastric carcinoma cells, this study sought to elucidate the mechanisms through which esomeprazole enhances cisplatin's cytotoxicity, potentially allowing for effective treatment with reduced cisplatin dosages. SNU‐1 cells were treated with varying doses of esomeprazole and cisplatin, alone and in combination. Cell viability was assessed using the XTT assay. Oxidative stress (TAS/TOS), apoptosis (Annexin V, cleaved PARP), mitochondrial membrane potential, and DNA damage (8‐oxo‐dG, γH2AX, ATM) were evaluated using flow cytometry and ELISA. Statistical significance was determined by ANOVA. Esomeprazole alone showed no significant effect on SNU‐1 cell viability, oxidative stress (TAS/TOS), apoptosis, mitochondrial membrane potential, or DNA damage. Cisplatin, however, significantly reduced cell viability (IC50 = 3.024 µg/mL), increased oxidative stress (decreased TAS, increased TOS), diminished apoptosis (increased Annexin V binding and cleaved PARP levels), disrupted mitochondrial membrane potential, and caused significant DNA damage (increased H2AX and ATM phosphorylation, and elevated 8‐oxo‐dG) ( p < 0.001). Notably, the combination of esomeprazole and cisplatin synergistically enhanced cisplatin's effects. The combination resulted in a significantly greater reduction in cell viability (CI < 1), a further increase in oxidative stress, a higher level of apoptosis, amplified mitochondrial depolarization, and potentiated DNA damage compared to cisplatin alone ( p < 0.001). Esomeprazole potentiates cisplatin‐induced cytotoxicity in SNU‐1 gastric cancer cells by enhancing oxidative stress, apoptosis, mitochondrial dysfunction, and DNA damage. This suggests a potential therapeutic strategy to improve cisplatin efficacy and overcome resistance in gastric cancer.


  • Open Access

    Osteoporosıs In Chronıc Kıdney Dısease

    by Duygu Felek, Mustafa Asım Gedikli

    Introduction: Bone mineral density disorders are more common in hemodialysis patients than in the general population. However, treatments to increase bone mineral density may increase vascular complications in hemodialysis patients. Bone mineral supplementation treatment regimens that do not increase hemodialysis-related cardiac mortality are necessary. Method: Thirty-three individuals (mean age 72.36±6.55 years; 20 females, 13 males) on hemodialysis for chronic kidney disease were included in the study. Body mass index, calcium, phosphorus, parathormone, bone densitometry results were recorded. In addition, the presence of intravascular calcification in the aorta on radiographs taken within the last 6 months was recorded. The relationships between these parameters were analyzed. Data were analyzed in SPSS. p< 0.05 was taken as the significance criterion. Results: When the dexa scores of 33 individuals with stage 5 CKD on hemodialysis were analyzed, the difference between T scores and PTH values was found to be significant (p=0.020*). As PTH increases, the risk of osteoporosis also increases. Osteopenia and osteoporosis were observed less in individuals with high calcium-phosphorus product. However, the difference between intravascular calcification and calcium-phosphorus product was significant (p=0.004*). The calcium-phosphorus product was significantly higher in the group with extensive aortic calcification compared to the other groups. Calcium-containing agents given with osteoporosis treatment increase cardiovascular mortality in stage-5 chronic kidney disease. Conclusion: Bone mineral density disorders should be treated in hemodialysis patients without increasing vascular calcification. In hemodialysis patients with high risk of cardiovascular disease, osteopenic follow-up can be performed by considering the benefit-harm relationship.

  • Open Access

    AFTER THE EARTHQUAKES WITH EPICENTER IN KAHRAMANMARAŞ ON FEBRUARY 6, 2023; CRUSH SYNDROME

    by Muhammed Faruk Aşkın, Şeyma Taştemur, Mustafa Asım Gedikli, Ferhan Candan, Yener Koc

    Objective: One of the vital problems after earthquakes that caused many deaths and injuries is crush syndrome due to traumatic muscle damage. The aim of this study was to determine the clinical course of patients with crush syndrome and identify factors that may be associated with crush syndrome. Methods: After the two earthquakes of 7.7 and 7.6 magnitude affecting 11 provinces with the epicentre in Kahramanmaraş on 6 February 2023, 319 patients over the age of 18 were admitted to our hospital between 6-14 February. 87 of 319 patients received inpatient follow-up and treatment. The age, gender, duration of stay in the rubble, province of residence, operation performed, duration of hospital stay, amount of fluid given in the first 24 hours, amount of urine output in the first 24 hours, body trauma sites, some laboratory parameters at the time of admission and during follow-up were retrospectively evaluated from the hospital records of all 43 patients diagnosed with crush syndrome among the inpatients between 6-28 February. Results: The age of the patients was 39±19.6 years, duration of stay under the cave-in(hours) 22.74±36.32, duration of hospitalization(days) 7.26±5.42, amount of fluid given in the first 24 hours(ml) 4954.18±3142, amount of urine output in the first 24 hours(ml) 2646.42±2262.65, admission creatinine(mg/dl) 1.59±2.25, admission creatine kinase(CK)(U/L) 11716.37±18520. 44.2% of the patients were female, 72.1% came from Kahramanmaraş province, 46.5% underwent surgical intervention, 67.4% had an admission CK above 1000 u/l, 14% received hemodialysis treatment and 51.2% had a duration of hospitalization longer than 21 days. The effect of other parameters on the duration of hospitalization and the time to reach the reference range of CK and correlation with laboratory parameters were analysed. Conclusion: As a result, it is thought that the parameters affecting the time to reach the CK reference range and the duration of hospitalization can be used to calculate and reduce the duration of hospitalization in prospective crush syndrome cases.


  • Open Access

    Determination of the Percentage of Patients Using Warfarin to Reach Target INR

    by Zekeriya Keskin, Mustafa Asım Gedikli

    Objective: Warfarin is the most commonly used oral anticoagulant in the treatment and prophylaxis of thromboembolic diseases. In order to prevent thrombosis and to avoid hemorrhagic complications, the patient's International Normalized Ratio (INR) is kept within a certain range according to the indication and monitored at certain intervals. Our aim in our study is to determine the percentage of patients using warfarin for various indications reaching target INR values. Methods: Patients who used warfarin for various indications at our hospital's Internal Medicine outpatient clinic between May 2023 and November 2023 were included in our study, and their INR results were recorded by retrospectively scanning them. Results: A study group was formed with a total of 130 patients. Patients using warfarin due to metallic heart valve replacement, AF, PTE and CVD were evaluated separately according to the target INR value. The percentage of patients with metallic heart valve replacement reaching the target INR value of 2.5-3.5 was calculated as 38.5% (n: 27). The percentages of patients with AF, PTE and CVD reaching their target INR values of 2-3 were calculated as 40% (n:16), 54% (n:7), 70% (n:5), respectively. Considering the entire study group, the percentage of reaching the target INR was calculated as 42% (n: 55). Conclusion: As a result, warfarin not being within the therapeutic range causes serious morbidity and mortality. In our study, the percentage of patients reaching the target INR was found to be 42%. This percentage is very low, and in order to increase this rate, it is necessary to increase patient awareness, increase the frequency of follow-up of patients and develop more effective follow-up strategies.


  • Open Access

    Retrospective Detection of Adrenal Incidentaloma Prevalence on Computed Tomography in a District Hospital

    by Zekeriya Keski̇n, Mustafa Asım GEDİKLİ

    Giriş: Görüntüleme yöntemlerinin artması ile birlikte adrenal insidentaloma (Aİ) daha sık görülür olmuş, çoğu non-fonksiyonel adenom olmasına rağmen malignite ve hormonal olarak aktif olabilmeleri nedeniyle önemli bir klinik problem haline gelmiştir. Bu çalışmanın amacı yetişkin yaş popülasyonunda adrenal insidentaloma prevalansının saptanmasıdır. Materyal Metod: Hastanemizde Şubat 2022 ile Eylül 2023 arasında çekilmiş kontrastlı ve kontrastsız abdomen BT görüntüleri tarandı. 18 yaş altı olan hastalar, kanser öyküsü olan ve metastaz şüphesi bulunan hastalar ve künt travma, delici kesici alet yaralanması, ateşli silah yaralanması gibi travmatik sebeplerle acil servise başvurmuş hastalar dahil edilmedi. Bu kriterlere uyan hasta grupları dışarıda bırakıldığında toplam 908 hasta ile çalışma grubu oluşturuldu. Adrenal lezyonun lokalizasyonu, boyutu, hiperplazi ve kalınlaşma gibi özellikleri ile hastaların görüntüleri normal, hiperplazik ve adenom olanlar şeklinde sınıflandırıldı. Bulgular: Çalışmaya 18 yaş üstü 908 hasta alınmıştır. 18 ile 64 yaş arası olan hastalar çalışma grubunun % 67’sini oluşturmakta iken, 65 yaş üstü hastalar %33’ünü oluşturmuştur. Adenom % 1 oranında izlendi. Bu adenomlardan 3’ü 18-64 yaş arasında görülürken 65 yaş üstünde 6 adenom görülmüştür. Tüm yaş gruplarında Aİ prevalansı %1, 18-64 yaş arası %0,5 ve 65 yaş üstü hastalarda % 2 olarak hesaplanmıştır. Sonuç: Görüntüleme yöntemlerinin sıklığının artması sebebiyle adrenal insidentaloma daha fazla görülmekte ve ciddiye alınması gereken bir tıbbi problem haline gelmektedir. Aİ prevalansının doğru saptanması bu hastalığın bilinirliğini artıracaktır. Böylece Aİ saptanan hastalarda uygun incelemeler sonrası, uygun tedavilerle tespit edilen hastalığa bağlı morbidite ve mortalite de azalma sağlanacaktır.